• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Changes in life expectancy and life span equality during the COVID-19 epidemic in 2020-22 in Japan

tetano

Editor, Senior Moderator
PLoS One


. 2026 Apr 29;21(4):e0345579.
doi: 10.1371/journal.pone.0345579. eCollection 2026.
Changes in life expectancy and life span equality during the COVID-19 epidemic in 2020-22 in Japan

Yuta Okada[SUP] 1 [/SUP], Hiroshi Nishiura[SUP] 1 2 [/SUP]


Affiliations
Abstract

Objectives: Life expectancy at birth is a demographic measure derived from age-specific mortality rates, reflecting the population's mortality pattern and its changes over time. While life expectancy has been heavily applied to quantify the mortality impact of the COVID-19 pandemic, the present study not only decomposes the changes in life expectancy by age and cause of death but also assesses the shifts in the age pattern of mortality in Japan. With this aim, we first evaluated the relationship between life expectancy gap from 2020-21 and 2021-22 and indicators of COVID-19 epidemic size at prefectural level. We also conducted age- and cause-specific decomposition of life expectancy change. Trends of life span equality from 2000-22 were also evaluated at the national level. Prefectural analysis between 2021-22 life expectancy change and annual per-population COVID-19 cases, person days in intensive care, reported COVID-19 deaths did not reveal significant correlations, which was contrary to our analysis from 2020-21. However, decomposition analysis revealed substantial life expectancy shortening attributable to the over-35-year-old population, and large increases in death causes such as cardiovascular or respiratory disorders along with COVID-19. For the total population in Japan, life span equality, an inverse measure of the dispersion in ages at death (higher values indicate less variation), declined in 2020 but increased in 2021 and 2022 despite the shortening in life expectancy. There were several key findings in this work. First, the discrepancy between life expectancy change and COVID-19 statistics in 2022 may, among other factors, possibly be attributable to the growing ascertainment bias of COVID-19. Second, the increased contribution of cardiovascular disorders to life expectancy shortening is an alarming sign for the future. Third, Life span equality in 2021 and 2022 is likely attributed to increased mortality among the elderly.


 
Back
Top